Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, and RNA modifications and cancer.
Exploring the Expression of CD73 in Lung Adenocarcinoma with <i>EGFR</i> Genomic Alterations.
Shifting from Immunohistochemistry to Screen for <i>ALK</i> Rearrangements: Real-World Experience in a Large Single-Center Cohort of Patients with Non-Small-Cell Lung Cancer.
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies?
Reference standards for gene fusion molecular assays on cytological samples: an international validation study.
A Real-World Experience from a Single Center (LPCE, Nice, France) Highlights the Urgent Need to Abandon Immunohistochemistry for ROS1 Rearrangement Screening of Advanced Non-Squamous Non-Small Cell Lung Cancer.
The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d'Azur, Nice, France).
Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens.
Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications
Fusion-positive non-small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications.
Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer
Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France).
Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer.
Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network
Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images.
Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing.
A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects.
Analytical validation of automated multiplex chromogenic immunohistochemistry for diagnostic and predictive purpose in non-small cell lung cancer.
Daily Practice Assessment of <i>KRAS</i> Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner.
Deciphering the Impact of <i>HER2</i> Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches.
Comparison of Two Rapid Assays for the Detection of <i>BRAF</i> V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes.
[Oncothoracic pathology seminar: Case No. 2].
[Oncothoracic pathology seminar: Case No. 1].
Morphologic and molecular classification of lung neuroendocrine neoplasms.
Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network
Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study
Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System.
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay.